Tech Center 3700 • Art Units: 1631 3774
This examiner grants 48% of resolved cases
Teresa Marie Dudden works in Art Unit 1631 within Tech Center 3700. The examiner has 27 resolved cases and an allowance rate of 48.1%. This rate indicates a challenging environment for patent applicants. The median days to allowance is 1405, providing a timeline for successful prosecution.
The interview lift is 45.2%, suggesting that interviews are an effective way to increase the chances of allowance relative to the 48.1% baseline. Practitioners should strongly consider an interview to take advantage of the 45.2% lift. The 27 resolved cases offer a baseline for these metrics.
In Tech Center 3700, the 48.1% allowance rate and 1405-day median timeline offer a strategic path for applicants in Art Unit 1631. Utilizing the 45.2% interview lift can significantly improve outcomes. These data points are essential for informed decision-making.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18450614 | COMMISSURE ATTACHMENT FEATURE STRESS ISOLATION | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18015136 | TISSUE EXPANSION DEVICE WITH FLUID COLLECTION | Non-Final OA | ALLERGAN, INC. |
| 18274682 | Rotatable Hip Prosthesis | Final Rejection | Emory University |
| 17831565 | DEVICES AND METHODS FOR SEMI-RIGID BONE FIXATION | Non-Final OA | DePuy Synthes Products, Inc. |
| 17918028 | BONE IMPLANT | Non-Final OA | Aesculap AG |
| 18780203 | PROSTHETIC HEART VALVE HAVING FRAME WITH VARYING STRUT LENGTHS | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 17982915 | KINK-RESISTANT EXPANDABLE SHEATH | Non-Final OA | Edwards Lifesciences Corporation |
| 17811737 | DEFLECTABLE SHAFTS FOR DELIVERY SYSTEMS | Final Rejection | Edwards Lifesciences Corporation |
| 17567508 | TISSUE REMODELING SYSTEM AND METHODS | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 17897789 | TISSUE REPAIR IMPLANT AND COMPOSITIONS AND METHOD OF IMPLANTATION | Final Rejection | Smith & Nephew Asia Pacific Pte. Limited |
| 17875114 | BIOACTIVE SCAFFOLD AUGMENTATION FOR ACL RECONSTRUCTION | Final Rejection | Smith & Nephew Asia Pacific Pte. Limited |
| 18841368 | PROSTHETIC HEART VALVE | Non-Final OA | Medtronic, Inc. |
| 18054165 | ARTHROPLASTY IMPLANT SYSTEMS WITH STEMLESS IMPLANTS | Non-Final OA | ARTHREX, INC. |
| 18227664 | ANATOMICALLY SHAPED STEMLESS SHOULDER FOR TOTAL SHOULDER REPLACEMENT AND REVERSE TOTAL SHOULDER | Non-Final OA | Zimmer, Inc. |
| 17791751 | MOBILE BEARING REVERSED HUMERAL IMPLANT | Non-Final OA | ZIMMER, INC. |
| 18654653 | TRANSLUMINAL STENTS AND RELATED METHODS | Non-Final OA | Merit Medical Systems, Inc. |
| 17995776 | VALVE DELIVERY SYSTEM | Non-Final OA | SHIFAMED HOLDINGS, LLC |
| 17760030 | ACCOMMODATING INTRAOCULAR LENSES AND ASSOCIATED METHODS | Final Rejection | Shifamed Holdings, LLC |
| 17757301 | ANCHORING MEMBER FOR A JOINT REPLACEMENT | Non-Final OA | WALDEMAR LINK GMBH & CO. KG |
| 17757241 | JOINT PROSTHESIS | Non-Final OA | WALDEMAR LINK GMBH & CO. KG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy